Outlook Therapeutics OTLK

$ 2.28 10.68%

Annual report 2024
added 12-27-2024

Outlook Therapeutics EV/EBITDA Ratio 2011-2025 | OTLK

Annual EV/EBITDA Ratio Outlook Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-3.04	-1.36	-1.17	-1.95	-1.42	-1.56	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-1.17	-3.04	-1.75